Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Jimmy Henry

Pain Medicine New Albany, OH Medical Doctor

NPI 1548483670 CMS profile 70236

5051 Forest Dr, New Albany, OH 43054

Open in the dashboard

General payments

$13,709

325 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Jimmy Henry of New Albany, OH is reported in the CMS Open Payments database as having received $13,709 across 325 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $45 1
2020 General $3,412 79
2019 General $10,252 245

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jimmy Henry
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Jimmy Henry were reported at $0. Among 1,144 Pain Medicine profiles paid that year, the median was $402 and the middle half received between $130 and $1,173.

Show as a table
Year Jimmy Henry Pain Medicine median Middle half National median
2019 $10,252 $409 $115–$1,311 $163
2020 $3,412 $214 $66–$666 $114
2021 $0 $299 $84–$899 $132
2022 $45 $335 $103–$1,149 $149
2023 $0 $376 $114–$1,228 $160
2024 $0 $387 $115–$1,173 $164
2025 $0 $402 $130–$1,173 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Boston Scientific Corporation $9,253 44 payments
  2. Vertos Medical, Inc. $794 7 payments
  3. Collegium Pharmaceutical, Inc. $485 44 payments
  4. Pfizer Inc. $444 37 payments
  5. Zyla Life Sciences $337 28 payments
  6. Horizon Therapeutics plc $260 23 payments
  7. Abbott Laboratories $245 14 payments
  8. US WorldMeds, LLC $180 13 payments
  9. Salix Pharmaceuticals, a division of Bausch Health US, LLC $172 12 payments
  10. Biodelivery Sciences International, Inc. $171 15 payments
  11. Other $1,369 88 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,600 4 payments
  2. Food and Beverage $5,020 307 payments
  3. Travel and Lodging $1,054 4 payments
  4. Education $35 10 payments
Products named General payments · program years 2019–2022
  1. SPECTRA WAVEWRITER $6,882 8 payments
  2. CLICK $1,600 1 payment
  3. mild Device Kit $794 7 payments
  4. XTAMPZA $475 42 payments
  5. GENERAL PAIN MANAGEMENT $404 13 payments
  6. LYRICA $337 28 payments
  7. SPRIX $227 17 payments
  8. ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH $158 14 payments
  9. SPRINT PNS System $146 2 payments
  10. Superion ISS $144 14 payments
  11. Other $2,940 224 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

325 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record